Cervarix two-dose HPV vaccine administration now approved for girls aged 9 to 14

Cervarix two-dose HPV vaccine administration now approved for girls aged 9 to 14

SINGAPORE - Girls, aged 9 to 14, in Singapore can opt for a easier implementation schedule for human papillomavirus (HPV) vaccination. Singapore has approved a two-dose administration of cervical cancer vaccine Cervarix for girls aged 9 to 14, said GlaxoSmithKline in a press statement.

Two studies that assessed the effectiveness and safety of Cervarix found that two doses in 9 to 14 year old girls are comparable to three doses in 15 to 25 year old girls and women. In one study, the results were sustained for a total of four years.

The new two-dose schedule of Cervarix is available to girls aged 9 to 14 years as an alternative to the current three-dose schedule. Cervarix is indicated in females from 9 to 25 years of age for the prevention of persistent infection, premalignant cervical lesions and cervical cancer caused by Human Papillomavirus Types 16 & 18.

At present, the three-dose schedule remains the only licensed indication for girls and women aged 15 years and above.

More about

Vaccines
Purchase this article for republication.

BRANDINSIDER

SPONSORED

Most Read

Your daily good stuff - AsiaOne stories delivered straight to your inbox
By signing up, you agree to our Privacy policy and Terms and Conditions.